James New

Chief Executive Officer at

Wavodyne Therapeutics, Inc.

72 year

77 connections

Health Technology

Consumer Services

Commercial Services

Profile

James New is the founder of Wavodyne Therapeutics, Inc. Former positions include Chief Executive Officer at Abrika Pharmaceuticals LLP from 2002 to 2007, President & Chief Executive Officer at Veloxis Pharmaceuticals A from 2008 to 2009, Chief Executive Officer at AIKO Biotechnology, Inc., President & Chief Executive Officer at Synaptogenix, Inc. in 2014, Director at Neurotrope, Inc. in 2014, Principal at Bristol Myers Squibb Co. from 1980 to 1992, Principal at Pfizer Inc. from 1994 to 1999, Principal at Novartis AG from 1999 to 2001, and Principal at GSK Plc.
Education includes an undergraduate degree from State University of New York College at Geneseo, a doctorate from State University of New York at Buffalo, a graduate degree from the University of Maine, and an MBA from Columbia Business School.

James New active positions

Companies	Position	Start
Wavodyne Therapeutics, Inc. Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuroinflammatory processes	Chief Executive Officer	-

All active positions of James New

Former positions of James New

Companies	Position	End
NEUROTROPE, INC.	Chief Executive Officer	15/07/2014
SYNAPTOGENIX, INC.	Chief Executive Officer	15/07/2014
VELOXIS PHARMACEUTICALS A/S	Chief Executive Officer	31/12/2008
Abrika Pharmaceuticals LLP Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals	Chief Executive Officer	31/12/2006
NOVARTIS AG	Corporate Officer/Principal	-

See the detail of James New's experience

Training of James New

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James New's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Abrika Pharmaceuticals LLP Abrika Pharmaceuticals LLP Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals	Health Technology
Veloxis Pharmaceuticals A/S Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients	Health Technology
AIKO Biotechnology, Inc. AIKO Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides commercial physical research solutions and services	Commercial Services
Neurotrope, Inc. Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurodegenerative diseases	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
GSK Plc GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products	Health Technology
State University of New York College at Geneseo State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Maine University of Maine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Synaptogenix, Inc. Synaptogenix, Inc. Packaged SoftwareTechnology Services Develops decentralized blockchain network that focuses on convergence between cryptocurrency and artificial intelligence	Technology Services
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Wavodyne Therapeutics, Inc. Wavodyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuroinflammatory processes	Health Technology

See company connections